@unclineberger
North Carolina's only public comprehensive cancer center, serving patients at the N.C. Basnight Cancer Hospital. Today's best care. Tomorrow's best hope. https://unclineberger.org/
Rathmell and Sharpless
NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at @unclineberger.bsky.social symposium
https://cancerletter.com/the-cancer-letter/20250919_1/
We’re halfway through Day 1 of the UNC Lineberger Scientific Symposium, and what an inspiring morning it’s been! From powerful insights on cancer care, prevention, and biology—our speakers are delivering.
Onsite registration is open, or join us virtually anytime: unclineberger.org/symposium/
Big thank you to Cristy Page, MD, MPH, Interim CEO and Dean, UNC Health and UNC School of Medicine, for stopping by the UNC Lineberger scientific symposium to speak to the scientists, clinicians, and advocates in attendance. unclineberger.org/symposium/
UNC Lineberger's executive director Robert Ferris, MD, PhD,
kicks off the 48th annual scientific symposium in Chapel Hill.
Scientists, clinicians, and advocates from across the cancer research spectrum are here to celebrate five decades of innovation, collaboration, and impact.
Kicking off 50 years of @unclineberger.bsky.social with @robertferrismdphd.bsky.social & the 48th Annual Scientific Symposium… looking forward to hearing the amazing reflections on #50years of #cancerresearch!
We love Shelley Earp, MD! 🩵
@unclineberger.bsky.social
Thrilled to catch Yue Xiong, PhD, Chief Scientific Officer, Cullgen Inc., at the 48th Annual UNC Lineberger Scientific Symposium.
He’ll be presenting “Targeted Protein Degradation for Drug Discovery"
Register free now, in-person or via livestream!
👉 unclineberger.org/symposium/registration/
Excited for the UNC Lineberger Scientific Symposium!
Session: Julian Downward, PhD, at the Francis Crick Institute on “Targeting the nexus of RAS oncogenic signaling and tumour immune evasion.”
Free to attend: unclineberger.org/symposium/re...
Don’t miss this session at the UNC Lineberger Scientific Symposium!
Join us on Wednesday, Sept. 10 for a presentation by Elaine Mardis, PhD, Co-Executive Director of the Institute for Genomic Medicine at Nationwide Children's Hospital & Professor of Pediatrics at The Ohio State University.
Don’t miss Edison Liu, MD of @jacksonlab.bsky.social at the 48th Annual UNC Lineberger Scientific Symposium!
His presentation: “Genomic biology of triple negative breast cancer: from treatment to prevention”
📅 Sept. 9–10 | Chapel Hill + Virtual
🔗 unclineberger.org/symposium/re...
Don’t miss Melissa B. Davis, PhD of the Morehouse School of Medicine at the 48th Annual UNC Lineberger Scientific Symposium!
Her presentation: “The Grand Challenge of Inequities: From the DARC side to SAMBAI."
📅 Sept. 9–10 | Chapel Hill + Virtual
🔗 unclineberger.org/symposium/re...
On Tuesday, Sept. 9, at the UNC Lineberger Scientific Symposium, Lewis Cantley, PhD, renowned Professor of Cell Biology at @harvardmed.bsky.social and a pioneer in kinase research, will deliver a groundbreaking presentation. Register today! unclineberger.org/symposium/re...
Join us on Tuesday, Sept. 9 at the UNC Lineberger Scientific Symposium, as Tony Hunter, PhD, Professor and Renato Dulbecco Chair in Cancer Research, presents: “What we have learned from 45 years of studying tyrosine phosphorylation and how it has impacted cancer therapy.”
On Tuesday, Sept. 9 at the UNC Lineberger Scientific Symposium, Arlene Sharpe, MD, PhD, Chair of Immunology at @harvardmed.bsky.social, will present: “Multifaceted functions of the PD-1 pathway.” Register here: unclineberger.org/symposium/re...
Don’t miss this session at the UNC Lineberger Scientific Symposium!
On Tues., Sept. 9, join Stephanie Wheeler, PhD, MPH, for her presentation: “Community, collaboration, cooperation, creativity: foundations for improving cancer care and outcomes in North Carolina.” unclineberger.org/symposium/re...
Join us on Tuesday, Sept. 9, for a must-see talk by Kevan Shokat, PhD, Professor of Cellular & Molecular Pharmacology at UC San Francisco: “Overcoming the undruggable nature of the common human oncogene K-Ras." unclineberger.org/symposium/re...
Join us on Tuesday, Sept. 9 at the UNC Lineberger Scientific Symposium, as W. Kimryn Rathmell, CEO of Ohio State’s James Cancer Hospital & Solove Research Institute, delivers a must-see talk. unclineberger.org/symposium/re...
Don’t miss this session at the 48th annual UNC Lineberger Scientific Symposium!
Tuesday, Sept. 9, UNC Lineberger's Kurt M. Ribisl, PhD, will present: “Advancing the promise of cancer prevention through interdisciplinary science.” Register here: unclineberger.org/symposium/re...
Join us Sept 9–10 for the 48th UNC Lineberger Scientific Symposium! Don’t miss William Kaelin, MD, PhD, of @danafarber.bsky.social, discussing “The VHL tumor suppressor gene: insights into oxygen sensing, cancer, and drugging the undruggable." unclineberger.org/symposium/re...
Mark your calendars! On Day 2 of the UNC Lineberger Scientific Symposium (Wed., Sept. 10), join Kwok-Kin Wong, MD, PhD, Professor of Medicine at NYU Langone Health, as he delivers his talk “Lung squamous cell carcinoma and novel therapeutic strategies.” unclineberger.org/symposium/re...
Join us Sept 9–10 for the 48th UNC Lineberger Scientific Symposium! Don’t miss MelissaTroester, PhD delving into “Improving breast cancer outcomes with multimodal data.” A must-see for anyone passionate about data-driven solutions in oncology. unclineberger.org/symposium/re...
July is Sarcoma Awareness Month
“These are really rare cancers that come from bone and soft tissue,” says UNC Lineberger's Jake Stein, MD, MPH.
Discover how recent advances in targeted therapies, immunotherapy, and radiation techniques are enhancing patient outcomes.
UNC Lineberger’s Comprehensive Cancer Support Program offers online yoga and meditation resources for cancer patients, caregivers and survivors.
Today at #ASCO25, Paola Zagami, MD, will present at the oral abstract session on the impact of ovarian function suppression with adjuvant endocrine therapy on survival outcomes in young germline BRCA mutation carriers with breast cancer: Secondary analysis of an international cohort study.
Today at #ASCO25, Jared Weiss, MD, will present at the poster session: (Poster 445) Versatile-002: Overall survival of HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma patients treated with T cell stimulating immunotherapy PDS0101 and pembrolizumab.
At #ASCO25 this morning, Tracy Rose, MD, MPH, will present at the poster session: (Poster 403) Pathologic response and safety of neoadjuvant pembrolizumab with or without entinostat in muscle-invasive urothelial cancer (MIUC).
⌚️: 9 a.m. - 12 p.m. CT
📍: Hall A
At #ASCO25 this morning, Yara Abdou, MD, MSCR, will present at the poster session: (Poster 120) Real-world analysis of characteristics and risk of recurrence in Black patients (pts) with HR+/HER2− early breast cancer eligible for NATALEE.
⌚️: 9 a.m. - 12 p.m. CT
📍: Hall A
Today at #ASCO25, Catherine Fahey, MD, PhD will provide the medical oncologist perspective at the Genitourinary Cancer — Kidney and Bladder case-based panel.
⌚️: 8 - 9 a.m. CT
📍: Hall B1
Kyle Lavin, MD, MPH, standing in front of research poster.
Junlone Moy, PharmD, RPh, and Amber Cipriani, PharmD, BCOP, standing in front of research poster.
At #ASCO25, Kyle Lavin, MD, MPH, & Junlone Moy, PharmD, RPh, (w/Amber Cipriani, PharmD, BCOP) presented, respectively, on enhancing patient QOL and mental health through collab care and bringing acad precision oncology to community settings @ASCO Care Delivery & Quality Care session. @UNCPharmacy
This afternoon at #ASCO25, Daniel Richardson, MD, MSc, MA, will present at the rapid oral abstract session: Treatment preferences between survival and quality of life and their association with clinical outcomes in older adults with advanced cancer.
⌚️: 5:06 p.m. - 5:12 p.m. CT
📍: S402